Home
Browse Measures
Expert Commentaries
Measure Matrix
Selecting and Using Measures
Compare Measures
Frequently Asked Questions
Submit Measures
About
myNQMC
Visit the U.S. Department of Health and Human Services Measure Inventory.

New This Week

View older issues in the New This Week Archive.

Withdrawn Summaries

The summaries listed below have been withdrawn from the NQMC Web site because they are no longer in current use and therefore, do not meet the NQMC Inclusion Criteria. Please see the Measure Archive for a complete list of all measures that have been withdrawn from the NQMC Web site.

January 26, 2015

Measure Summaries
Institute for Clinical Systems Improvement 
National Committee for Quality Assurance 
Withdrawn Summaries
Centers for Medicare & Medicaid Services 
-
End stage renal disease (ESRD): percentage of adult (greater than or equal to 18 years old) hemodialysis and peritoneal dialysis patients, with ESRD greater than or equal to 3 months, who had received ESA therapy at any time during a 3 month study period AND who had Hb values reported for at least 2 of the 3 study months AND have achieved a mean hemoglobin of 10.0-12.0 g/dL for the 3 month study period.
-
End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) hemodialysis and peritoneal dialysis patients prescribed an ESA at any time during the study period or who have a Hb less than 11.0 g/dL in at least one month of the study period for whom serum ferritin concentration AND either percent transferrin saturation or reticulocyte Hb content (CHr) are measured at least once during the study period for in-center hemodialysis patients, and at least twice during the study period for peritoneal dialysis patients and home hemodialysis patients.
-
End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) hemodialysis and peritoneal dialysis patients, with ESRD greater than or equal to 3 months and who had Hb values reported for at least 2 of the 3 study months, who have a mean Hb less than 10.0 g/dL for a 3 month study period, irrespective of ESA use.
-
End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) in-center hemodialysis patients in the sample for analyses for whom delivered hemodialysis dose was calculated using UKM or Daugirdas II during the study period and for whom the frequency of hemodialysis per week is specified.
-
End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) patients in the sample for analysis who have been on hemodialysis for 90 day or more and dialyzing thrice weekly, and have a residual renal function (if measured in the last three months) less than 2 ml/min/1.73m2, whose delivered dose of hemodialysis (calculated from the last measurements of the month using the UKM or Daugirdas II formula) was a spKt/V greater than or equal to 1.2 during the reporting period.
-
End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) peritoneal dialysis and hemodialysis patients included in the sample for analysis with serum calcium measured at least once within a month.
-
End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) peritoneal dialysis and hemodialysis patients included in the sample for analysis with serum phosphorus measured at least once within a month.
-
End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) peritoneal dialysis patients with total solute clearance for urea (endogenous residual renal urea clearance & dialytic) measured at least once in a four month time period.
-
End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) peritoneal dialysis patients with weekly Kt/V urea (endogenous residual renal urea clearance & dialytic) calculated in a standard way.
-
End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) hemodialysis patients in the sample for analyses with documented monthly adequacy measurements (spKt/V) or its components in the calendar month.
Institute for Clinical Systems Improvement 
-
Diagnosis and management of type 2 diabetes mellitus in adults: percentage of patients with type 2 diabetes mellitus with A1c test in the last year greater than 9%.
-
Diagnosis and management of type 2 diabetes mellitus in adults: percentage of patients with type 2 diabetes mellitus with blood pressure measurement in the last year and greater than 150/90 mmHg.